HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis

Lignende værker

• HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series
  af: Seidel, Sabine, et al.
  Udgivet: (2020)
• Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome
  af: Seidel, Sabine, et al.
  Udgivet: (2021)
• High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity
  af: Sabine Seidel, et al.
  Udgivet: (2022-04-01)
• OS08.8 A head-to-head comparison of two different high dose methotrexate (HDMTX) - and high dose cytarabin (HDAraC)-based chemotherapy regimens in younger patients with primary central nervous system lymphoma (PCNSL)
  af: Rieger, L., et al.
  Udgivet: (2017)
• Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
  af: Seidel, Sabine, et al.
  Udgivet: (2020)